Furong Liu, X. Long, Bi-xiang Zhang, Wanguang Zhang, Xiaoping Chen, Zhanguo Zhang
tlooto Summary
It was showed that pancreatic injury can occur in some COVID-19 patients, and angiotensin-converting enzyme 2 (ACE2), the receptor of SARS-CoV-2, in the pancreas, was explored.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that causes coronavirus disease 2019 (COVID-19) in human beings, has caused a serious public health issue.1 Attention to pancreatic injury is lacking, which may impact patients’ prognosis. In this study, we explored the expression and distribution of angiotensin-converting enzyme 2 (ACE2), the receptor of SARS-CoV-2, in the pancreas. Combined with clinical data, we showed that pancreatic injury can occur in some COVID-19 patients.
Citation format
LIU, Furong, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clinical Gastroenterology and Hepatology, 2020, 18: 2128–2130.e2.